drugset / Trial / NCT01088919

A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy Subjects

NCT01088919

Phase 1 Completed 64 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to evaluate pharmacokinetics, pharmacodynamics and safety following the administration of ASP1941 and pioglitazone hydrochloride in multiple and single doses.

Timeline

Start
2009-11
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule Oral
Subject ipragliflozin Small molecule Oral

Indications

No indication recorded.